People · Operator
Named in public records as an officer, director or promoter · active 2010–2023 · Manufacturing, Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Oxane Materials Inc | — | Manufacturing | Series C | $178.3M | $61.6M | 2010 |
| Twister Biotech, Inc. | — | Biotechnology | Seed | $1.6M | $3.9M | 2020 |
Christopher Coker at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Christopher Coker on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Greg Williams | 1 | 11 |
| Evan Davies | 1 | 3 |
| Gregory Williams | 1 | 3 |
| George Coyle | 1 | 2 |
| James Sledzik | 1 | 2 |
| Stephen Douglas | 1 | 2 |
| Michael Pavia | 1 | 2 |
| Harald P Stanzer | 1 | 1 |
| Christopher P Coker | 1 | 1 |
| Norbert Czaszar | 1 | 1 |
| Elliott Kruppa | 1 | 1 |
| Alex Steven | 1 | 1 |
| Mark Matovich | 1 | 1 |
| Lynn Zechiedrich | 1 | 1 |
| Stephen Holditch | 1 | 1 |
| Benjamin Yi | 1 | 1 |
| Andrew Barron | 1 | 1 |
| David Pursell | 1 | 1 |
| Harald Stanzer | 1 | 1 |
| Norbert Csaszar | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.